SPONSOR
Fudan University
Total Trials
37
Recruiting
37
Phases
Phase 2, Phase 3, Phase 1, Phase 1, Phase 2
Conditions studied: Pancreatic CancerRadiotherapyColorectal CancerMicrosatellite Stable Colorectal CarcinomaBreast CancerTransformed LymphomaOvarian CancerNasopharyngeal Cancinoma (NPC)NSCLC Stage IVSolid Tumor
NCT06249321 Phase 2
Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
Pancreatic Cancer
NCT05771181 Phase 2
Recruiting
Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients
Colorectal Cancer
NCT07117630 Phase 2
Recruiting
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
Breast Cancer
NCT06743945 Phase 2
Recruiting
POLA-R-CHP in the First-line Treatment of Transformed DLBCL
Transformed Lymphoma
NCT04520074 Phase 3
Recruiting
Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)
Ovarian Cancer
NCT07067268 Phase 2
Recruiting
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
Nasopharyngeal Cancinoma (NPC)
NCT06313541 Phase 2
Recruiting
Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line Immunotherapy
NSCLC Stage IV
NCT06394622 Phase 1
Recruiting
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors
Solid Tumor
NCT04781270 Phase 3
Recruiting
mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases
Colorectal Carcinoma
NCT06763029 Phase 2
Recruiting
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
Colorectal Cancer Metastatic
NCT04383275 Phase 2
Recruiting
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
Breast Cancer
NCT07398937 Phase 2
Recruiting
Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC
Resectable Stage II-IIIa Squamous NSCLC
NCT07272382
Recruiting
Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer
Esophageal Neoplasms
NCT07371273 Phase 2
Recruiting
Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR
Colorectal Cancer
NCT07183280
Recruiting
Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas
Solid Pseudopapillary Neoplasm of the Pancreas
NCT05760391
Recruiting
A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.
Metastatic Esophageal Squamous Cell Carcinoma
NCT06634966 Phase 3
Recruiting
Segmentectomy for Solid-dominant Lung Cancer
Segmentectomy
NCT06406426 Phase 2
Recruiting
Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Cadonilimab and Fruquintinib Combined With Paclitaxel-albumin
Gastric / Gastroesophageal Junction Adenocarcinoma
NCT07362810 Phase 2
Recruiting
G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
NCT05032768
Recruiting
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
Radiation Dermatitis
NCT06914674 Phase 2
Recruiting
Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Pancreatic Neoplasms
NCT06786169
Recruiting
The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
Gastric Cancer, Gastroesophageal Junction Cancer
NCT06966154 Phase 1, Phase 2
Recruiting
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL
Natural Killer/T-cell Lymphoma
NCT06462053 Phase 2
Recruiting
Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal Cancer
Early Low Rectal Cancer
NCT07003022 Phase 2
Recruiting
Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC
Colo-rectal Cancer
NCT06670495
Recruiting
HPV Genotype Attribution and Disease Burden of Anal Cancer in China
Anal Cancer
NCT06387628 Phase 2
Recruiting
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
TNBC - Triple-Negative Breast Cancer
NCT06121700 Phase 2
Recruiting
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer
Adenocarcinoma
NCT05901428 Phase 3
Recruiting
TCb vs EC-T in High Risk ER+/HER2- Breast Cancer
Hormone Receptor Positive HER-2 Negative Breast Cancer
NCT06517004 Phase 1
Recruiting
An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma
NCT06793332 Phase 2
Recruiting
BrAin Metastasis in TripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
Triple-Negative Breast Cancer (TNBC)
NCT06749015
Recruiting
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
Metastatic Colorectal Cancer
NCT06841159 Phase 2
Recruiting
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
Microsatellite Stable Metastatic Colorectal Cancer
NCT05443841
Recruiting
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
Esophageal Cancer
NCT06903325
Recruiting
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
Colorectal Cancer
NCT06738160 Phase 2
Recruiting
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
NSCLC
NCT06560840
Recruiting
Effectiveness of Gut Microbiota-targeted Diatery Intervention Among Older People Living With HIV
Hiv